ORTHOXEL DESIGNATED ACTIVITY COMPANY

OrthoXel Designated Activity Company is a forward‑thinking medical‑device developer specialising in orthopaedic trauma solutions. Drawing on close collaboration with surgeons, the company designs and launches intramedullary nailing systems that aim to improve fracture healing and patient outcomes. Its flagship Apex range – including tibial, femoral retrograde and femoral antegrade nails – is the first and only line to combine controlled axial micromotion with exceptional torsional stability, promoting secondary bone healing while maintaining robust fixation.

In addition, OrthoXel offers the Vertex Hip Fracture Nailing System, a versatile platform that incorporates a fluted nail stem, interdigitating screws and a stability‑focused set screw to deliver optimal stability for complex hip fractures. Although the Vertex system is not yet available within the European Union, the company’s commitment to innovation is evident through its ongoing research and development, supported by a dedicated Insight Support service and regular newsletters for clinicians.

Headquartered in Cork, Ireland, OrthoXel serves orthopaedic surgeons and trauma specialists worldwide, delivering cutting‑edge fixation technology that challenges the accepted standards of fracture care.